PROGNOSTIC MARKERS IN RESECTABLE NON–SMALL CELL LUNG CANCER
Data up to Jan 2025
Total Citations Per Year
Abstract
References (87)
Cancer statistics, 1996
1996 • 1,807 citations
A New International Staging System for Lung Cancer
1986 • 1,652 citations
Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor
1986 • 1,226 citations
Incidence of local recurrence and second primary tumors in resected stage I lung cancer
1995 • 971 citations
K-rasOncogene Activation as a Prognostic Marker in Adenocarcinoma of the Lung
1990 • 811 citations
Relation of neovascularisation to metastasis of non-small-cell lung cancer
1992 • 780 citations
Prognosis and survival in resected lung carcinoma based on the new international staging system
1988 • 708 citations
High levels of p53 protein in UV-irradiated normal human skin.
1993 • 689 citations
bcl-2 Protein in Non-Small-Cell Lung Carcinoma
1993 • 684 citations
Keynote address on biostatistics and data retrieval.
1973 • 476 citations
p185neu expression in human lung adenocarcinomas predicts shortened survival.
1990 • 440 citations
Postsurgical Stage I Bronchogenic Carcinoma: Morbid Implications of Recurrent Disease
1984 • 386 citations
Accumulation of p53 protein correlates with a poor prognosis in human lung cancer.
1992 • 384 citations
Clinical significance of ras oncogene activation in human lung cancer
1993 • 361 citations
The Effect of Surgical Treatment on Survival from Early Lung Cancer
1992 • 353 citations
p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity.
1986 • 341 citations
Prognostic significance of p53 mutations and 3p deletions in primary, resected non-small cell lung cancer
1995 • 333 citations
Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence
1995 • 323 citations
Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases
1996 • 314 citations
Commentary from Westminster
1984 • 309 citations
A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression.
1995 • 300 citations
Lung cancer detection results of a randomized prospective study in Czechoslovakia
1986 • 290 citations
Prognostic factors in patients with resected stage I non-small cell lung cancer. A report from the Lung Cancer Study Group
1984 • 279 citations
Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation
1993 • 275 citations
ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intent.
1991 • 249 citations
Correlation of Expression of H/LeY/LeBAntigens with Survival in Patients with Carcinoma of the Lung
1992 • 235 citations
Screening for Lung Cancer
1989 • 231 citations
Expression of Blood-Group Antigen A — A Favorable Prognostic Factor in Non-Small-Cell Lung Cancer
1991 • 221 citations
Mutations of the p53 Gene as a Predictor of Poor Prognosis in Patients With Non-Small-Cell Lung Cancer
1993 • 213 citations
Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer
1995 • 201 citations
Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma
1991 • 185 citations
Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small-cell lung cancer.
1994 • 183 citations
C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas.
1994 • 182 citations
PLOIDY AS A PROGNOSTIC DETERMINANT IN SURGICALLY TREATED LUNG CANCER
1987 • 174 citations
Frequency and Distribution of Occult Micrometastases in Lymph Nodes of Patients With Non-Small-Cell Lung Carcinoma
1993 • 173 citations
Survival after resection of stage II non-small cell lung cancer
1992 • 170 citations
Screening for Lung Cancer
1997 • 168 citations
Histopathologic prognostic factors in adenocarcinomas of the peripheral lung less than 2 CM in diameter
1988 • 161 citations
Expression of p53 oncoprotein in non-small-cell lung cancer: a favorable prognostic factor.
1995 • 160 citations
Prognostic impact of mutated K-ras gene in surgically resected non-small cell lung cancer patients
1994 • 156 citations
The relationship of p53 immunostaining to survival in carcinoma of the lung
1992 • 147 citations
Molecular and pathologic markers in stage I non-small-cell carcinoma of the lung.
1995 • 141 citations
Five-year follow-up study of independent clinical and flow cytometric prognostic factors for the survival of patients with non-small cell lung carcinoma.
1988 • 141 citations
Site of Recurrence in Patients with Stages I and II Carcinoma of the Lung Resected for Cure
1981 • 141 citations
p53 Alterations in non-small cell lung cancers correlate with metastatic involvement of hilar and mediastinal lymph nodes
1994 • 133 citations
Prognostic significance of abnormal p53 accumulation in primary, resected non-small-cell lung cancers.
1996 • 133 citations
Prognostic implications of the International Staging System for Lung Cancer.
1988 • 132 citations
Altered Retinoblastoma Protein Expression and Prognosis in Early-Stage Non-Small-Cell Lung Carcinoma
1994 • 130 citations
Overexpression of the c‐erbB‐2/neu–encoded p185 protein in primary lung cancer
1992 • 129 citations
Blood vessel invasion by tumor cells predicts recurrence in completely resected T1 N0 M0 non-small-cell lung cancer
1993 • 119 citations
Prognostic factors in surgically resected limited-stage, nonsmall cell carcinoma of the lung
1984 • 116 citations
Postresection Irradiation for T2 N0 M0 Non–Small Cell Carcinoma: A Prospective, Randomized Study
1996 • 103 citations
Surgical results and prognostic factors of pathologic N1 disease in non-small-cell carcinoma of the lung
1994 • 100 citations
Prognostic significance of the expression ofras oncogene product in non-small cell lung cancer
1992 • 98 citations
Nonanatomic prognostic factors in carcinoma of the lung. A multivariate analysis
1982 • 96 citations
Postoperative T1 N0 non-small cell lung cancer
1987 • 93 citations
Prognostic and therapeutic significance of the flow cytometric nuclear DNA content in non-small cell lung cancer
1990 • 91 citations
National survey of the pattern of care for carcinoma of the lung
1990 • 82 citations
Is T factor of the TNM staging system a predominant prognostic factor in pathologic stage I non-small-cell lung cancer ? A multivariate prognostic factor analysis of 151 patients.
1993 • 82 citations
Prognostic significance of p53 andras p21 expression in nonsmall cell lung cancer
1995 • 81 citations
Prognostic Significance of the Proliferation Index in Surgically Resected Non—Small-Cell Lung Cancer
1993 • 79 citations
The effect of tumor size and tumor cell DNA content on the survival of patients with stage I adenocarcinoma of the lung
1989 • 79 citations
Symptomatic Patterns, Biologic Behavior, and Prognosis in Cancer of the Lung
1964 • 77 citations
Immunohistochemical study of cathepsin B. Prognostic significance in human lung cancer
1994 • 76 citations
Correlation of expression of ABH blood group carbohydrate antigens with metastatic potential in human lung carcinomas
1993 • 74 citations
Preoperative carcinoembryonic antigen level as a prognostic indicator in resected primary lung cancer
1994 • 73 citations
Is T factor of the TNM staging system a predominant prognostic factor in pathologic stage I non-small-cell lung cancer?
1993 • 67 citations
Flow cytometric analysis of the DNA content of non-small cell lung cancer ploidy as a significant prognostic indicator in squamous cell carcinoma of the lung
1990 • 66 citations
Proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions as factors influencing prognosis of surgically treated lung cancer patients.
1993 • 65 citations
Limitation of annual screening chest radiography for the diagnosis of lung cancer. A retrospective study
1993 • 62 citations
Prognostic factors in resected stages I and II adenocarcinoma of the lung
1990 • 58 citations
Current status of screening for lung cancer.
1994 • 55 citations
The percentage of aneuploid cells is significantly correlated with survival in accurately staged patients with stage 1 resected squamous cell lung cancer and long-term follow up
1989 • 54 citations
Molecular Foundations of Oncology
1992 • 52 citations
A flow cytometric study of non-small cell lung cancer classified as T1N0
1992 • 47 citations
Expression of Lewis-related antigen and prognosis in stage I non—small cell lung cancer
1995 • 39 citations
Prognostic significance of parenchymal lymphatic vessel and blood vessel invasion in carcinoma of the lung.
1983 • 34 citations
Prognostic significance of basement membrane deposition in operable squamous cell carcinomas of the lung
1991 • 30 citations
DNA content in correlation with postsurgical stage in non-small cell lung cancer
1992 • 28 citations
Immunostains for blood group antigens lack prognostic significance in T1 lung carcinoma
1995 • 28 citations
Prognostic implications of histopathologic subtyping in patients with surgically treated stage I or II adenocarcinoma of the lung
1989 • 27 citations
Prognostic significance of serum ca 125 antigen assay in patients with non-small cell lung cancer
1994 • 26 citations
Use of Tumor Markers in Lung Cancer
1994 • 23 citations
Long-term survival of patients with lung cancer from a defined geographical area before and after radiological screening
1996 • 6 citations
The molecular biology of lung cancer
1991 • 4 citations
Results of resection for bronchogenic carcinoma in patients over the age of 80
1994 • 2 citations
The clinical significance of ras oncogene mutations in non-small cell lung cancer
1994 • 1 citations
Cited By (0)
No citing papers found in database